RNN – release of Zoraxel P2a results QCOR – advisory committee meeting scheduled for Acthar (drug for treatment of infantile spasms) on May 6 POZN – PDUFA date for VIOMOVO on 4/30 CYTX – APOLLO and PRECISE trial results to be presented at meeting on May 7 HRBR – release of Triolex P2 results in obese type 2 diabetes patients BNVI – possible partner for Menerba IVD – possible FDA decision on MAGO4S 510K submission THTCF.PK (also on Toronto exchange: TH.TO) – advisory committee meeting on May 27 PTN - Potential partner for CHF drug. HNAB.OB - potential runup in anticipation of ASCO presentation.
To all - please do your own DD before investing. This post is just a starting point for your own DD.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.